158 related articles for article (PubMed ID: 1331590)
1. Antagonistic activity of Y-25130 on 5-HT3 receptors.
Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M
Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.
Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S
Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198
[TBL] [Abstract][Full Text] [Related]
4. Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130.
Yakushiji T; Akaike N
Br J Pharmacol; 1992 Nov; 107(3):853-7. PubMed ID: 1472977
[TBL] [Abstract][Full Text] [Related]
5. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
[TBL] [Abstract][Full Text] [Related]
6. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
7. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
[TBL] [Abstract][Full Text] [Related]
8. [High affinity binding of Y-25130 for serotonin 3 receptor].
Sakamori M; Takehara S; Setoguchi M
Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):137-42. PubMed ID: 1330854
[TBL] [Abstract][Full Text] [Related]
9. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
10. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Sakamori M; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition by Y-25130 of the von Bezold-Jarisch effect evoked by 5-HT or 2-methyl-5-HT in anesthetized rats].
Inaba K; Morimoto Y; Fukuda T; Setoguchi M
Nihon Yakurigaku Zasshi; 1991 Oct; 98(4):293-9. PubMed ID: 1802816
[TBL] [Abstract][Full Text] [Related]
15. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.
Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP
Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715
[TBL] [Abstract][Full Text] [Related]
16. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.
Butler A; Elswood CJ; Burridge J; Ireland SJ; Bunce KT; Kilpatrick GJ; Tyers MB
Br J Pharmacol; 1990 Nov; 101(3):591-8. PubMed ID: 2076479
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists.
Kawakita T; Kuroita T; Yasumoto M; Sano M; Inaba K; Fukuda T; Tahara T
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):624-30. PubMed ID: 1611677
[TBL] [Abstract][Full Text] [Related]
19. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
20. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
